Biotechnology: Biological Products (No Diagnostic Substances)

AwardJun 23, 2026, 04:31 PM

DBV Technologies Joins Euronext Tech Leaders Index

AI Summary

DBV Technologies announced its inclusion in the Euronext Tech Leaders index, effective June 22, 2026. This index highlights high-growth European companies across technology and related sectors, recognizing their innovation and growth trajectory. CEO Daniel Tassé stated that this recognition reflects the strength of their science and progress in developing the VIASKIN® Peanut Patch for peanut allergy.

Key Highlights

DBV Technologies included in the Euronext Tech Leaders index.
Inclusion went into effect on June 22, 2026.
The index spotlights high-growth European companies in technology and adjacent sectors.
DBV Technologies is a clinical-stage biopharmaceutical company.
The company is advancing the VIASKIN® Peanut Patch for peanut allergy treatment.

View SEC Filing

DBVT

Biotechnology: Biological Products (No Diagnostic Substances)

DBV Technologies S.A.

Price Impact